Sherwin-Williams (SHW) Tops Q3 EPS by 11c, Offers Q4 Guidance

Sherwin-Williams (NYSE: SHW) reported Q3 EPS of $3.97, $0.11 better than the analyst estimate of $3.86. Revenue for the quarter came in at $3.15 billion versus the consensus estimate of $3.25 billion.

Sherwin-Williams sees Q4 2015 EPS of $1.70-$1.95, versus the consensus of $1.89.

• For the fourth quarter, we anticipate our consolidated net sales will be up low single digits compared to last year's fourth quarter.

For earnings history and earnings-related data on Sherwin-Williams (SHW) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• RCM Technologies (RCMT) Tops Q2 EPS by 17c